Literature DB >> 5418732

Heparin-accelerated inhibition of activated factor X by its natural plasma inhibitor.

E T Yin, S Wessler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5418732     DOI： 10.1016/0304-4165(70)90316-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  13 in total

1.  Potent direct inhibitors of factor Xa based on the tetrahydroisoquinoline scaffold.

Authors:  Rami A Al-Horani; Akul Y Mehta; Umesh R Desai
Journal:  Eur J Med Chem       Date:  2012-06-23       Impact factor: 6.514

2.  In vitro and in vivo correlation of clotting protease activity: effect of heparin.

Authors:  S N Gitel; R C Stephenson; S Wessler
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

3.  The current status of low-dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism.

Authors:  V V Kakkar
Journal:  World J Surg       Date:  1978-01       Impact factor: 3.352

Review 4.  Vascular problems. Clotting in arteries and veins.

Authors:  V V Kakkar
Journal:  Ann R Coll Surg Engl       Date:  1978-05       Impact factor: 1.891

5.  Venous thromboses in myocardial infarction. Comparison in heparin dosage.

Authors:  P G Habersberger; A Pitt; S T Anderson
Journal:  Br Heart J       Date:  1973-05

6.  Interaction of heparin with canine coagulation proteins: in vivo and in vitro studies.

Authors:  P A Gentry
Journal:  Can J Comp Med       Date:  1977-10

Review 7.  Pulmonary embolism: current therapeutic concepts.

Authors:  D A Tibbutt; C N Chesterman
Journal:  Drugs       Date:  1976       Impact factor: 9.546

8.  Human Recombinant Antithrombin (ATryn®) Administration Improves Survival and Prevents Intravascular Coagulation After Intraportal Islet Transplantation in a Piglet Model.

Authors:  Valery Gmyr; Caroline Bonner; Ericka Moerman; Antoine Tournoys; Nathalie Delalleau; Audrey Quenon; Julien Thevenet; Mikael Chetboun; Julie Kerr-Conte; François Pattou; Thomas Hubert; Merce Jourdain
Journal:  Cell Transplant       Date:  2016-10-27       Impact factor: 4.064

9.  Heparin-catalyzed inhibitor/protease reactions: kinetic evidence for a common mechanism of action of heparin.

Authors:  M J Griffith
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

10.  Control of heparin therapy.

Authors:  W R Pitney; J E Pettit; L Armstrong
Journal:  Br Med J       Date:  1970-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.